Jade Biosciences, Inc. (JBIO) Most Active Options
The 2 most actively traded Jade Biosciences, Inc. (JBIO) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.
Data as of Jul 10, 2026, 8:00 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.
Most Active JBIO Contracts
| Contract | Expiration | DTE | Last | IV | IV rank (30d) | Delta | Open interest | Volume | vs 30d avg |
|---|---|---|---|---|---|---|---|---|---|
| JBIO $20 put | Jul 17, 2026 | 7d | $1.00 | 103.5% | 0 | -0.34 | 80 | 80 | 3.0× avg |
| JBIO $25 call | Aug 21, 2026 | 42d | $0.10 | 137.1% | 45 | 0.45 | 26 | 3 | 10.2× avg |
Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.
The most active JBIO contract today is the $20 put expiring in 7 days, with 80 contracts traded.
Explore the payoff profile of option on JBIO for free
Build multi-leg JBIO strategies, visualize payoffs, and scan the full US options universe with OptiView.
JBIO Options FAQ
Which JBIO option contract is most active today?
The most traded JBIO contract is the $20 put expiring Jul 17, 2026, with 80 contracts traded as of Jul 10, 2026.
How does OptiView rank the most active JBIO options?
The table lists the 2 JBIO contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.
Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.
Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.